$MMEDF News
Last published 5y ago
- 5y agoMMDWFMMEDFMNMDMindMed Announces Project Angie, Targeting the Treatment of Pain with PsychedelicsPR NewswireNEW YORK, May 5, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. ("MindMed" or the "Company") (NASDAQ:MNMD) (NEO: MMED), (DE: MMQ), a leading psychedelic-inspired medicine company announces the launch of its Project Angie to advance the development of
- 5y agoMMEDFMNMDMindMed To Commence Trading on NasdaqPR NewswireNEW YORK, April 23, 2021 /PRNewswire/ -- MindMed (NASDAQ:MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been approved for listing on The Nasdaq Capital Marke
- 5y agoCMPSMMEDFMYCOFSILOWith Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly AcceptedPR NewswirePALM BEACH, Fla., April 22, 2021 /PRNewswire/ -- Global Psychedelic and Psilocybin Drugs market is growing rapidly due to the increasing number of depression cases and rising special designation from the regulatory authorities to the company to expedite
- 5y agoCLXPFFTRPFMCURFMMEDFPsychedelic Drugs Market Size Is Projected To Reach $10.75 Billion By 2027PR NewswirePALM BEACH, Fla., April 21, 2021 /PRNewswire/ -- The psychedelics industry has entered the spotlight! The rapidly increasing acceptance of psychedelic treatments is creating a strong demand from therapists and patients for access to the new products an
- 5y agoCMPSEHVVFMMEDFMYCOFThe Power of the Platform in Psychedelic MedicineGlobeNewswireATLANTA, April 20, 2021 (GLOBE NEWSWIRE) -- If you had a time machine and could go back to the first day of 2020, you would find that very few people were talking about psychedelics and their potential to save lives. OTC Stock Review introduced a large
- 6y agoMMEDFMind Medicine (MindMed) Inc (MMEDF) CEO JR Rahn on Q2 2020 Results - Earnings Call TranscriptEarnings Call Transcripts